Reuters logo
BRIEF-Forward Pharma appeals initial decision in U.S. patent interference to federal circuit
May 31, 2017 / 1:08 PM / in 5 months

BRIEF-Forward Pharma appeals initial decision in U.S. patent interference to federal circuit

May 31 (Reuters) - Forward Pharma A/S:

* Forward Pharma appeals the initial decision in the U.S. patent interference to the federal circuit

* Forward Pharma - filing of notice of appeal of PTAB decision that ended interference proceeding between forward 11/576,871 patent application and an issued Biogen patent

* Says appeal is expected to last ten months or longer Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below